Currently, testing the antipsychotic efficacy of CNO using schizophrenia animal models is underway in our laboratory to determine the possibility that CNO can be effective as a substitute of clozapine in treating this mental disease. This evidence concerns the gene BLOC1S4 and schizophrenia.